{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:17:12Z","timestamp":1791087432946,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/bor.0b013e32835f69b4","type":"journal-article","created":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T02:27:58Z","timestamp":1362104878000},"page":"310-316","source":"Crossref","is-referenced-by-count":45,"title":["New treatments for osteoarthritis"],"prefix":"10.1097","volume":"25","author":[{"given":"Elizabeth","family":"Smelter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc C.","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States.","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7326\/0003-4819-154-4-201102150-00001","article-title":"Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans.","volume":"154","author":"Losina","year":"2011","journal-title":"Ann Intern Med"},{"key":"R4-6-20210128","doi-asserted-by":"crossref","first-page":"d1165","DOI":"10.1136\/bmj.d1165","article-title":"All cause and disease specific mortality in patients with knee osteoarthritis: population based cohort study.","volume":"342","author":"Nuesch","year":"2011","journal-title":"BMJ"},{"key":"R5-6-20210128","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.joca.2010.09.013","article-title":"OARSI-FDA initiative: defining the disease state of osteoarthritis.","volume":"19","author":"Lane","year":"2011","journal-title":"Osteoarthritis Cart"},{"key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.21596","article-title":"American college of rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.","volume":"64","author":"Hochberg","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R7-6-20210128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pain.2009.06.024","article-title":"Duloxetine, a centrally acting analgesic, int the treatment of patients with osteoarthritis knee pain: a 13-week randomized, placebo-controlled trial.","volume":"146","author":"Chappel","year":"2009","journal-title":"Pain"},{"key":"R8-6-20210128","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1533-2500.2010.00401.x","article-title":"A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee.","volume":"11","author":"Chappel","year":"2011","journal-title":"Pain Practice"},{"key":"R9-6-20210128","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1185\/03007995.2011.633502","article-title":"Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial.","volume":"27","author":"Frakes","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3899\/jrheum.110307","article-title":"Clinically relevant outcomes based on analysis of pooled data from 2 trials of duloxetine in patients with knee osteoarthritis.","volume":"39","author":"Hochberg","year":"2012","journal-title":"J Rheumatol"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.immunol.16.1.27","article-title":"Interleukin-1 receptor antagonist: role in biology.","volume":"16","author":"Arend","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"R12-6-20210128","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/art.1780390914","article-title":"Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: suppression of collagenase-1 expression.","volume":"39","author":"Caron","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R13-6-20210128","first-page":"1317","article-title":"Safety study of intraarticular injection of interleukin-1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study.","volume":"32","author":"Chevalier","year":"2005","journal-title":"J Rheumatol"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/art.24096","article-title":"Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study.","volume":"61","author":"Chevalier","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R15-6-20210128","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.joca.2007.07.008","article-title":"Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a randomized controlled trial.","volume":"16","author":"Yang","year":"2008","journal-title":"Osteoarthritis Cart"},{"key":"R16-6-20210128","first-page":"1323","article-title":"Pilot study of TNF inhibition in erosiveinflammatory osteoarthritis of the hands.","volume":"34","author":"Magnano","year":"2007","journal-title":"J Rheumatol"},{"key":"R17-6-20210128","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/ard.2011.149849","article-title":"Tumor necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomized trial on structure modification.","volume":"71","author":"Verburggen","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R19-6-20210128","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa0901510","article-title":"Tanezumab for the treatment of pain from osteoarthritis of the knee.","volume":"363","author":"Lane","year":"2010","journal-title":"NEJM"},{"key":"R20-6-20210128","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.joca.2011.01.009","article-title":"Long-term open-label study of tanezumab for moderate to severe osteoarthritis knee pain.","volume":"19","author":"Schnitzer","year":"2011","journal-title":"Osteoarthritis Cart"},{"key":"R21-6-20210128","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.joca.2011.09.006","article-title":"Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study.","volume":"19","author":"Nagashima","year":"2011","journal-title":"Osteoarthritis Cart"},{"key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jpain.2012.05.006","article-title":"Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial.","volume":"13","author":"Brown","year":"2012","journal-title":"J Pain"},{"key":"R24-6-20210128","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard.2007.075572","article-title":"Effects of strontium ranelate on spinal osteoarthritis progression.","volume":"67","author":"Bruyere","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R25-6-20210128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1359\/jbmr.2001.16.2.299","article-title":"Strontium ranelate increases cartilage matrix formation.","volume":"16","author":"Herrotin","year":"2001","journal-title":"J Bone Miner Res"},{"key":"R27-6-20210128","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s11999-008-0569-9","article-title":"Use of bone morphogenic protein-7 as a treatment for osteoarthritis.","volume":"467","author":"Badlani","year":"2009","journal-title":"Clin Orthop Rela Res"},{"key":"R28-6-20210128","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1471-2474-11-232","article-title":"Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis.","volume":"11","author":"Hunter","year":"2010","journal-title":"BMC Musculoskel Dis"},{"key":"R29-6-20210128","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.berh.2010.03.001","article-title":"Pharmacotherapy: concepts of pathogenesis and emerging treatments. Novel targets in bone and cartilage.","volume":"24","author":"Beyer","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R31-6-20210128","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pmrj.2010.02.011","article-title":"Efficacy of intra-articular botulinum toxin type A in painful knee osteoarthritis: a pilot study.","volume":"2","author":"Boon","year":"2010","journal-title":"PM R"},{"key":"R32-6-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1759720X09357113","article-title":"Botulinum toxin therapy for osteoarticular pain: an evidence-based review.","volume":"2","author":"Singh","year":"2010","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R33-6-20210128","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00007256-200939050-00002","article-title":"Platelet-rich therapies in the treatment of orthopaedic sport injuries.","volume":"39","author":"Sanchez","year":"2009","journal-title":"Sports Med"},{"key":"R34-6-20210128","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1423-0410.2006.00815.x","article-title":"Platelet content and growth factor release in platelet rich plasma: a comparison of four different systems.","volume":"91","author":"Leitner","year":"2006","journal-title":"Vox Sanguinis"},{"key":"R35-6-20210128","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00167-009-0940-8","article-title":"Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions.","volume":"18","author":"Kon","year":"2010","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"R36-6-20210128","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s00167-010-1238-6","article-title":"Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis.","volume":"19","author":"Filardo","year":"2011","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"R37-6-20210128","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/PHM.0b013e3181fc7edf","article-title":"Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study.","volume":"89","author":"Sampson","year":"2010","journal-title":"Am J Phys Med Rehabil"},{"key":"R38-6-20210128","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.arthro.2011.05.011","article-title":"Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis.","volume":"27","author":"Kon","year":"2011","journal-title":"Arthroscopy"},{"key":"R39-6-20210128","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/PHM.0b013e3182aab72","article-title":"Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid.","volume":"91","author":"Spackova","year":"2012","journal-title":"Am J Phys med Rehabil"},{"key":"R40-6-20210128","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1756-185X.2011.01599.x","article-title":"Mesenchymal stem cell therapy for knee osteoarthritis: preliminary report of four patients.","volume":"14","author":"Davatchi","year":"2011","journal-title":"Int J Rheum Dis"},{"key":"R41-6-20210128","first-page":"422","article-title":"Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis.","volume":"15","author":"Emadedin","year":"2012","journal-title":"Arch Iran Med"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e32835f69b4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:17:35Z","timestamp":1786040255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-201305000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e32835f69b4","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}